Nalbuphin OrPha, Injektionslösung

7680569890026 CH-56989 Injektionslösung
Nalbuphin OrPha, Injektionslösung
Nalbuphin OrPha, Injektionslösung
1 / 2
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
10 x 2
Selling units
10
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
13/11/2024
Summary of Product Characteristics
Français
13/11/2024
Summary of Product Characteristics
Italien
13/11/2024

Detailed composition

Substance Quantity Type Category
nalbuphini hydrochloridum
20.0 MG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
acidum citricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.64 MG Substance HBESI

Authorization holder

OrPha Swiss GmbH

8700 Küsnacht ZH

Authorization information

Swissmedic authorization number
56989
Drug name
Nalbuphin OrPha, Injektionslösung
Galenic form
LSINJ
ATC Code
N02AF02
Authorization status
Z
Dispensing category
A
First authorization
15/10/2004
Authorization expiration date
31/12/9999
IT Number
01.01.3.
Domain
Human medicine
Field of application
Mittelschwere bis schwere Schmerzen

Package details

Description (FR)
NALBUPHIN OrPha sol inj 20 mg/2ml 10 amp 2 ml
Description (DE)
NALBUPHIN OrPha Inj Lös 20 mg/2ml 10 Amp 2 ml
Market launch
15/10/2004
Narcotic (BTM)
No
Buy us a coffee Explore the data